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Abstract 
On the cusp of massive commercialization of nanotechnology-enhanced products and 
services, the physical and chemical analysis of nanoparticles in human specimens merits im-
mediate attention from the research community as a prerequisite for a confident clinical in-
terpretation of their occurrence in the human organism. 
In this review, we describe the caveats in current practices of extracting and isolating 
nanoparticles from clinical samples and show that they do not help truly define the clinical 
significance of any detected exogenous nano-sized objects. Finally, we suggest a systematic 
way of tackling these demanding scientific tasks. 
More specifically, a precise and true qualitative evaluation of nanoparticles in human 
biological samples still remains difficult to achieve because of various technical reasons. 
Such a procedure is more refined when the nature of the pollutants is known, like in the case 
of nano-sized wear debris originating from biomedical prostheses. Nevertheless, nearly all 
available analytical methods provide unknown quantitative accuracy and qualitative precision 
due to the challenging physical and chemical nature of nanoparticles. 
Without trustworthy information to detect and describe the nanoparticulate load of clinical 
samples, it is impossible to accurately assess its pathological impact on isolated cases or al-
low for relevant epidemiological surveys on large populations. Therefore, we suggest that the 
many and various specimens stored in hospitals be used for the refinement of methods of ex-
haustive quantitative and qualitative characterization of prominent nanoparticles in complex 
human milieu. 
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 Introduction 
The terminology used in the field of nanotechnology and associated subfields is under 
constant refinement. In 2011, the term “nanomaterial” was defined by the European Commis-
sion (EC) as “a natural, incidental or manufactured material containing particles […] (of 
which) one or more external dimensions is in the size range 1nm - 100nm [1]. In late 2014, 
feedback from various laboratories helped revise this recommendation based on how it inte-
grated with the challenges in their fields of work. In the current review the term “nanoparti-
cle” (NP) will be used to signify nano-sized pieces of matter, of either spherical or near-
spherical, platelet, flake and fibrous shape as clarified by the EC in a recently published JRC 
report [2]. 
Over the past 15 years, it has become apparent that an unequivocal understanding of 
long-term repercussions on human health upon exposure to NP constitutes an almost inordi-
nate task. One can argue that this is because of two reasons: first, NP are created with a high 
degree of physical and chemical variability; second, their properties may undergo alterations 
during their life-cycle. The physicochemical variety of nanoparticulate formulations and their 
unstable nature renders their most fundamental properties (surface chemistry, aggregation 
state, etc.) difficult to measure and hinders the evaluation of their effects on living organisms 
and the environment. Consequently, the toxicokinetics and toxicodynamics of NP are multi-
parametric and prohibitively time-consuming to estimate. A study in 2009 suggested that it 
would require U.S. industries at least half a century to evaluate the toxicity of existing nano-
particles at the pace such test used to be undergone [3]. Under the current circumstances, the 
industrial world is adopting a “per case” approach to ensure that nanomaterials are manufac-
tured in a way that does not endanger the employees’ safety nor puts public health and the 
environment at risk [4]. In the past, though, chemical substances and materials of industrial 
interest were regulated only after their detrimental ramifications had manifested in individu-
 als, often as a result of high levels of occupational exposure; of the most notorious examples 
are vinyl chloride, trichloroethylene and asbestos. 
Asbestos is a thoroughly documented case, both toxicologically and epidemiological-
ly. It is a naturally occurring, fibrous and crystalline material that enjoyed widespread use 
thanks to its interesting thermal and mechanical properties, until it was indisputably linked to 
an array of lung diseases. The most severe of them was pleural mesothelioma, a rare form of 
cancer of the mesothelial tissue that lines the lungs and the chest wall [5]. In fact, there have 
been so many afflicted patients, that links have been established between exposure levels to 
airborne asbestos fibers, their deposition to the lungs and an eventual development of asbes-
tos-related diseases [6]. Although still under discussion, the onset of pathological conditions 
related to elevated asbestos exposure is believed to originate from the constant pro-
inflammatory state brought upon the frustrated phagocytosis of its highly biopersistent fibers 
of more than 15-20µm long - what is now referred to as the “fibrous toxicity paradigm” [7]. 
A similar pathogenic process has been proposed for the acute and chronic in vivo toxicity of 
long, thin, needle-like carbon nanotubes, imputed to traits similar to asbestos fibers, like ex-
tensive crystallinity and high aspect ratio [8, 9]. 
Scope and purpose of the review 
Our contention is that the analysis of nanoparticles in human biological matrices is 
being overlooked. On that ground, the purposes of this article are to pinpoint the challenges 
of detecting and adequately characterizing the nanoparticulate load of clinical samples and 
review their pathological significance. We have considered published studies of which the 
objectives were the detection of nanoparticles in human samples, the quantitative and / or 
qualitative analysis of said nanoparticles and the assessment of their clinical impact. Con-
versely, we have excluded studies that employed fluorescent or radiolabelled nanoparticles, 
as these are designed to be traceable and quantifiable by specific means that do not generally 
 apply. Finally, we have decided not to rehash studies on ultra-fine particles, given that their 
detection in the pulmonary tract and their effect on lungs and the cardiovascular system have 
been extensively reviewed over the past two decades [10, 11]. The relevant literature has 
been stratified into two groups: the first one includes studies for which the origin as well as 
the physicochemical nature of the nano-objects was a priori assumed. From an analytical 
standpoint, such knowledge is crucial for the successful isolation and characterization of the 
analyte. Inversely, the second group is about studies where the presence of nanoparticles in 
the samples was investigated as a possible explanation of the patients’ clinical condition. Ob-
viously, such research is more limited in terms of available technical tools and the medical 
interpretations of the findings are mostly conjectural. 
From a purely technical standpoint, there is an in-depth report that aptly describes the 
caution required when analysing NP in environmental and biological systems [12]. A similar 
perspective discusses how recent technical advances in environmental toxicology could boost 
the field of human nano-toxicology [13], but the scope of both articles focuses on techniques 
more suited for well-defined media and analytes. 
 
Nano-sized wear debris in periprosthetic tissues 
Orthopedic prostheses have been used for the past five decades to partially or com-
pletely replace arthritic or otherwise traumatized joint surfaces. These biomedical devices are 
engineered to be durable and to withstand heavy loads of weight. To this end, preferred mate-
rials are ultrahigh molecular weight polyethylene (UHMWPE), various metal alloys of mo-
lybdenum, chromium, cobalt and titanium, and ceramics (Al2O3, ZrO2, SiO2, among others), 
all of which show good biocompatibility in their bulk form. Once implanted, these devices 
are being subject to fretting which causes particulate debris to be released in the synovial cav-
ities and the periprosthetic tissues. As it was first verified for UHMWPE-based prostheses 
 and later for other types of materials, debris-induced inflammation can cause a loss of me-
chanical stability at the affected joint, a situation which sometimes requires a revision surgery 
to be performed [14]. This section discusses the ex vivo studies on periprosthetic samples that 
investigated the contained nanoparticulate wear debris. 
Clinical relevance 
Regardless of the artificial bone’s bulk materials, all types of debris have an inflam-
matory effect at the site of the replaced joint and usually cause pain, discomfort and might 
eventually reduce the motility of the patient. The pathological mechanism triggered by 
UHMWPE particles results in the aseptic loosening of the arthroplasty because of osteoclas-
tic bone resorption; this phenomenon, otherwise referred to as osteolysis, is initiated and 
maintained by the constant endocytosis of wear debris [15]. Prostheses with all-metal parts 
have been found to cause severe local tissue reactions as a result of metal hypersensitivity, 
manifesting in the form of aseptic lymphocytic vasculitis-associated lesions, metallosis and 
necrotic-appearing soft tissue masses [16]. To better understand the pathogenicity of metal 
and ceramic particles, in vitro studies have exposed phagocytic cells to debris generated in 
joint simulators [17, 18]. Although different cell types respond differentially to wear debris, it 
seems that its pathogenicity is overall dose-dependent [19, 20] and the elicited inflammatory 
responses also depend on the particles’ size and morphology [21]. When it comes to size, the 
equivalent circle diameter of debris can range from a few tens of nanometers to more than 10 
micrometers and it has been suggested that the sub-micrometric fraction is more readily 
phagocytized by macrophages [15]. At the nanoscale, the total surface of a given amount of 
debris dramatically increases and metal and ceramic particles can be more readily dissolved 
in the acidic environment of phagolysosomes. Thusly generated cations and complexes are 
suspected to hamper the cell’s homeostasis and be potentially cytotoxic or genotoxic [16, 22]. 
Another red flag is the ability of some nanoparticles to cross epithelial barriers and accumu-
 late in the liver and spleen [23]; nano-sized debris in specific has been suspected to travel 
through the lymphatic or circulatory system and  accumulate to lymph nodes far from the site 
of their introduction to the organism [24]. Therefore, while micrometer sized debris is spatial-
ly trapped close to the artificial joint, small enough particles might present a system-wide im-
pact. Sub-micron polyethylene and metal particles have been observed in the liver and spleen 
of patients who had previously undergone arthroplasties and a particular case of hepatosple-
nomegaly was associated with the presence of Ti-Al-Va alloy where it had brought upon the 
formation of granulomatous tissue [25, 26]. Figure 1 presents the possible local and systemic 
effects exerted by metal debris generated from the fretting of all-metal prostheses. 
In view of the oft-reported in vitro and in vivo toxicity of various nanomaterials and in 
conjunction with findings from relevant orthopedic studies, it is reasonable to be increasingly 
wary about the adverse effects of nano-sized wear debris. As it stands, debris’ size, chemical 
composition and total mass are the major determining factors of the onset and intensity of an 
inflammatory response. Therefore, techniques applied on retrieved tissues should enable the 
sensitive and accurate analysis of said parameters at the nanoscale. Various approaches for 
isolating wear debris from periprosthetic tissues have been developed since the early ‘80s but 
it was only in the last 15 years that researchers started examining the nano-sized subpopula-
tion of wear particles. In fact, these ex vivo studies are the first ever to have detected artificial 
nanoparticles in human samples and to have assessed their clinical importance. 
Extraction and analysis of nano-sized wear debris from periprosthetic samples 
By and large, the qualitative analysis of wear particles in periprosthetic tissues bene-
fits from the fact that the pollutants in question are of known chemical composition. This is a 
great asset in the hands of researchers as they can tailor their laboratory routines to fit either 
UHMWPE, metal or ceramic particles. Suggested procedures in the literature have a strong 
underpinning in established biochemical protocols, such as the fractionation of cellular com-
 ponents and the purification of proteins. During the past two decades, efforts have been made 
to adjust these practices to allow for the isolation of nanoparticles from biological media. To 
this end, three main steps are primarily followed: the digestion of the tissue, the centrifuga-
tion of the liquefied digest and the filtration of the part containing the wear debris. 
In order to compromise the samples’ cellular integrity and destroy their tissular struc-
ture (thus liberating entrapped wear debris), there are three available methods, namely the 
alkaline, acidic and enzymatic digestions. Each one of them has distinct advantages and dis-
advantages that have been discussed thoroughly elsewhere [27, 28]. In brief, the alkaline and 
acidic digestions are both very efficient at mineralizing organic matter, although they require 
rigorous precautionary measures. The enzymatic method is safer but more expensive, time-
consuming and might not hydrolyze completely all types of tissue. The benefit of knowing 
what kind of particles are to be encountered according to the materials of the prosthesis al-
lows for the most suitable reagents to be deployed. Table 1 summarizes the reagents and 
techniques deployed as well as the results from the most prominent clinical studies of the na-
noparticulate load of periprosthetic samples.  
Another two widely used techniques for the extraction of particles from periprosthetic 
samples are the centrifugation and the filtration of the homogenized digest. Centrifugation is 
employed in order to separate artificial particles from organic species based on their distinctly 
different densities when compared to the bulk liquid medium. Owing to buoyancy, polyeth-
ylene particles can float in the surface of the digest, whereas, upon centrifugation, metal and 
ceramic particles, being denser than the digest, move towards the bottom end of the tube [29, 
30].  
Membrane filtration is often the final step of existing methodologies and facilitates 
electron microscopy, x-ray spectroscopy and the weight measurement of extracted particles 
by depositing them on the filter surface after discarding the liquid medium into which they 
 were dispersed. With the use of field-emission gun scanning electron microscopy (FEG-
SEM) becoming more widespread, it became apparent that debris contained a subpopulation 
of particles which was small enough to pass through the filter pores when the latter measured 
larger than 100 nm in diameter [29, 31]. Smaller filter pores were, therefore, employed, but 
that introduced the need for multiple filtration steps in order to remove micron sized debris or 
undigested organic material that could clog the nano-sized pores [32].   
Some studies have been conducted by circumventing the digestion-centrifugation-
filtration procedure and solely observing the retrieved samples by means of a transmission 
electron microscope (TEM). The periprosthetic tissues are prepared according to standard 
TEM protocols which include fixation, dehydration, embedment in suitable resins and ultra-
thin sectioning of the sample [33-35]. In a recent study, Topolovec et al. noticed in a tissue 
section a population of nanoparticles with dimensions smaller than those detected after the 
same samples were treated with the digestion-centrifugation-filtration procedure, underlining 
the need of further optimization of this kind of protocols [36]. Figure 2 presents electron mi-
crographs from applying both procedures on periprosthetic samples.  
Unreliability of quantitative and qualitative data on nano-sized wear debris 
A methodology that could provide the quantitative analysis of the nanoparticulate load of 
biological samples (either in terms of total nano-particulate mass or absolute number of particles) 
is a glaring omission from the reviewed clinical studies. As such, if particles cannot be retrieved 
in full, the measured size distribution might be misleading: nanoparticles’ mass, size distribution 
and total surface are quantitative parameters that govern their toxic potential against living sys-
tems [37]. These properties unbeknownst, it becomes troublesome to establish unassailable links 
between particles found in patients’ samples and their respective symptomatology.  
Current digestion procedures have been developed with micrometer- or millimeter-
sized wear particles in mind [38] and might partially or entirely dissolve nano-sized counter-
 parts of larger particles. Firstly, the available surface for solid-liquid interactions vastly in-
creases at the nanoscale [39], thus accelerating the kinetics of dissolution of even stable metal 
oxides. In addition, an adaptation of their band gaps at the nanoscale might increase the ionic 
nature of the metal-oxygen bond [40]. To add yet another complication, liquefied samples are 
often filtered, but there is now compelling evidence that nanoparticles can get trapped in 
some fibrous matrices, introducing yet another bias on size distribution measurements [41]. 
The mass of most ions in a liquid sample is usually measured by means of inductively 
coupled plasma optical emission spectroscopy or mass spectroscopy (ICP-OES or ICP-MS, re-
spectively) [42, 43]. Despite their low detection limits and high accuracy, these techniques do not 
convey information on how mass is distributed within polydisperse populations of particles. Sin-
gle-particle ICP-MS (spICP-MS) is an emerging technique that resolves both the size and the di-
ameter of metal-containing nanoparticles [44]. In the work of Gray et al., beef tissue was spiked 
with near-spherical metal nanoparticles which were then quantitatively recovered and whose size 
was accurately measured [45]. Albeit promising, it must be noted that spICP-MS’ use is intended 
for particles of homogeneous composition and geometry, so further optimizations are necessary 
before it can be applied to biological samples containing nanoparticles of varied morphology and 
complex chemistry. 
In a notable nanometrology work, Fraikin et al. presented a micro-fluidic device adept at 
resolving the size and absolute concentration of sub-micron and nano-sized spherical particles 
[46]. Their detector has a stronger ability to resolve the size distribution of polydisperse particle 
populations compared to dynamic light scattering (DLS), while the refractive index of the ob-
served particles is not a prerequisite for the calculation of their absolute concentrations, in con-
trast to nanoparticle tracking analysis. Interestingly, the shape of UHMWPE particles tends to 
actually become spherical when their size drops below the 100 nm mark, as mentioned by Nine et 
al., making this detector seemingly poised for granulometric analyses of the synovial fluid around 
 joint prostheses [47]. 
A non-quantitative extraction of wear debris has also collateral effects on the qualitative 
description of the nano-debris because of non-representative sampling. The affected qualitative 
parameters are the particles’ morphology (shape, geometry and texture) and chemical identity 
(bulk composition and surface chemistry). These can be further distorted because of the powerful 
alkaline or acidic conditions employed for the sample's digestion: the aggregation state of nano-
particles can be skewed due to agglomeration or even aggregation upon steep changes in zeta-
potential [48, 31]. Furthermore, the ubiquitous process of centrifugation, has been noted to pro-
mote agglomeration of smaller particles and cause nanoparticles to strongly adhere to the walls of 
tubings because of van der Waals forces [49]. Finally, concerning their chemical identity, the sur-
face chemistry and composition of metallic wear debris can be altered due to passivation, while 
some alloys can be partially dissolved [50]. 
Figure 3 demonstrates examples of the most common methodological caveats that 
thwart the reliability of obtained quantitative and qualitative data on nano-sized wear debris. 
The potential role of nanoparticles’ biological coating 
Another possible culprit introduced by the use of strong hydrolyzing agents is the hydrol-
ysis of the nanoparticles’ protein and lipid coating. This bioorganic layer referred to as “protein 
corona”, has been shown to determine the colloidal properties of some types of nanoparticles 
[51]. Coronas also act as the nanoparticles' “biomolecular fingerprints“, influencing their patho-
physiological effect [52] with their biochemical composition and structural conformation appear-
ing to play key roles [53]. Interestingly, the corona is mainly composed of antibodies and com-
plement proteins that normally facilitate the uptake of pathogens by phagocytes in a process 
much similar to that of opsonization [54]. On this basis, mapping the wear debris’ corona could 
contribute to the engineering of better-tolerated materials. In the available literature, aggressive 
enzymatic or chemical treatment is the only way of extracting nanoparticles from tissular sam-
 ples, but these techniques might be avoidable for synovial fluid: secreted inside the joints, parti-
cles like crystals or other solid bodies can be extracted from this natural lubricant through non-
destructive treatments [55]. 
During the past decade, research on protein corona conflated proteomics and nanotoxicol-
ogy, with the majority of published articles exploring the effects of well-defined biological media 
(protein dispersions, sera, etc.) on well-characterized nanoparticles [56, 57]. However, in a more 
far-reaching study, Kapralov et al. isolated and purified single-walled carbon nanotubes from 
mouse alveolar lavage through a single-step gradient and allowed for the proteomic analysis of 
the CNT’s corona composition and spatial structure [58]. Single-step gradient centrifugations are 
simple procedures based on the different densities of biological species and most exogenous na-
noparticles. Upon their extraction, qualitative and quantitative assessments on nanoparticles 
along with the examination of their biomolecular corona should be feasible. 
Standard practices  
After decades of research on the degradation of implant materials, there are now two 
standardized practices available for the ex vivo treatment of biological samples, the extraction 
of contained debris and its characterization: the ASTM Standard F561-13 [59] and an interna-
tional standard issued by the International Standards Organisation (ISO) [60]. They both de-
scribe numerous available procedures on the digestion of organic material (alkaline, acidic 
and enzymatic) and provide adjustments to various samples, like tissues, synovial fluid or 
artificial wear test liquids. When it comes to the physical extraction of wear particles from a 
biological environment, both organizations introduce centrifugation of digests on variable 
density gradients and multiple wash cycles. On the whole, ASTM F561-13 provides more 
studious descriptions and proposes more elaborate chemical and physical treatments while 
ISO is being more succinct. Interestingly, despite the use of sophisticated lab equipment (ul-
tracentrifuge), relatively expensive reagents (enzymes) and procedures that require up to 4 
 working days per sample, neither of them claims to provide a quantitative retrieval of wear 
debris. On the other hand, both of them have been specifically updated so as to provide 
guidelines on the morphological characterization of any extracted population of nanoparti-
cles. In the 2013 revision of the ASTM F561 standard practice, two acclaimed studies by Bil-
li et al. that cater for the minimization of particle loss and their accurate qualitative character-
ization have been incorporated [61, 62]. More specifically, these two studies suggest a one-
step enzymatic digestion in tandem with density gradient centrifugation of tissue or liquid 
samples that deposits the extracted particles (polyethylene, metal or ceramic) onto a TEM 
grid or a Si wafer. They thus avoid any possible loss of particles that might incur during mul-
ti-step procedures, provide a snapshot of the dispersion state of particulate debris and allow 
for the observation of a number of instances large enough for the safe statistical analysis of 
the debris' morphological parameters. 
 
Nanoparticles in samples of patients with idiopathic diseases 
The second section of this review is dedicated to studies of bioptic material retrieved 
from patients that suffered from conditions for which the pathological cause was undefined. 
The pathological importance of nano-sized objects detected in these samples was the main 
clinical question addressed in those investigations. Here, the interest lies in reviewing the 
techniques employed for the detection of nanoparticles of unknown nature and quantity and 
what conclusions were made with regards to the patients’ symptomatology.  A summary of 
these studies is presented in Table 2.  
Clinical relevance of detected nanoparticles 
The association of random nanoparticulate findings with pathological conditions is 
not as easy to track as it is for nano-sized wear debris originating from prostheses for which 
 in vitro and in vivo studies delineate their pathogenicity against cells and tissues [16, 63]. The 
exploratory studies that will be presented hereafter had the objective to unravel possible 
causative links between idiopathic pathological conditions and various nanoparticles present 
in the affected part of the organism. Figure 4 presents two of the most striking cases that have 
been documented so far. 
 The first ever study of this sort examined biopsies from 12 patients who suffered 
from hepatic and / or renal failure [64]; interestingly, the initial samples’ histological exami-
nation described the cases as “granulomatosis of unknown origin”. Among them, one patient 
suffered from inflammatory chronic infiltrate and another presented with granuloma for-
mations. Eventually, particles of inorganic nature, specifically BaSO4 and Au nanoparticles, 
were detected in their biopsies. They were considered to be remnants of a previous examina-
tion and a colloidal-gold therapy therapeutic injection, respectively. The detection of nano-
particles at the diseased sites underscored the possibility that some idiopathic pathologies 
might be caused, aggravated by or be otherwise related to the presence of these artificial 
nano-objects. Upon this notion, the team coined the term “nano-pathology”. Two years later, 
the presence of inorganic nanoparticles in colon biopsies afflicted with Crohn’s disease, can-
cer or ulcerative colitis - all conditions of unknown origin - was investigated by the same 
team [65]. In a total of 16 samples, 3 retrieved from cancer patients showed nano-sized parti-
cles of zirconium, silicon and titanium, among other elements. An interesting observation 
was that the size of particles decreased in sites farther from the mucosa surface, suggesting an 
easier translocation of nanoparticles across the inflamed mucosal barrier, a concept that is 
now backed by several other studies [66, 67]. The discovery of particulate debris at the site of 
serious diseases challenged anew the concept of fully biocompatible materials and highlight-
ed the need to define the relation between ingested particles and idiopathic diseases. Gatti et 
al. conducted yet another two studies in which they examined the particulate retentate on ex-
 planted vena cava filters, i.e. removable biomedical devices implantable into the inferior vena 
cava which are intended to prevent pulmonary embolisms by entrapping and breaking up 
thrombi [68, 69]. In the two studies combined, there were 20 samples retrieved from an equal 
number of patients. Thirteen of them suffered from deep vein thrombosis concurrent with 
some other pathological condition; the remaining 7 had received the implant as part of a 
prophylactic treatment. On the isolated filters, clusters of nano-sized inorganic particles of 
exogenous origin (Pb, Ti, Cu) were observed, but information on their source of origin could 
not be extrapolated. Likewise, it was difficult to conclude if it were the nanoparticles that fa-
vored the formation of thrombotic masses or if the thrombi themselves swept the NP in the 
circulatory system. In any case, the studies underlined the importance of further exploring the 
compatibility of NP with blood components. 
In 2009, the first clinical report on the long-term toxicity of nanoparticles in humans 
was performed by Song et al. [70]. The patients were 7 women who had been suffering from 
shortness of breath and had amber-colored pleural and pericardial effusions prior to their ad-
mission to the hospital, pointing to physical or chemical pulmonary irritation. Although some 
biomarker values varied among them, they did share some major findings: they all presented 
at least some lung damage, nonspecific interstitial inflammation, inflammatory infiltration, 
pulmonary fibrosis and foreign body granulomas of the pleura; at the same time none of them 
had tumor markers or virological findings relevant to their clinical condition. They had all 
been working for several months in the same poorly ventilated environment and had been 
exposed to an airborne dust of polyacrylic ester which contained known carcinogens (eth-
ylene dioxide) as well as other dangerous substances (toluene), among others. It was also 
found that the airborne dust contained silica nanoparticles of a diameter ranging from 2 to 30 
nm. Said nanoparticles were spotted in the chest fluid, in mesothelial cells of the pleural fluid 
as well as in various cells and structures of the macrophages and in bioptic lung tissue (in 
 blood and lymphatic vessels, endothelial cells). The fact that the clinical image of the patients 
continued to deteriorate months after their removal from their workplace, led the medical 
team to consider the detected nanoparticles as one of the causes behind their condition. Their 
claims were predicated on certain in vitro and in vivo studies which found amorphous silica 
nanoparticles to have a toxic effect on cells and tissues through oxidative stress, genotoxic 
and inflammatory phenomena. However, the conclusion that silica nanoparticles are culpable 
for the pathological findings can only be tentative given that the examined patients had been 
exposed to a host of toxic substances and that artificial nano-sized objects were effectively 
cleared through the lymphatic system over the course of their treatment. 
To our knowledge, the two most recent clinical studies are the works carried out by 
Wu et al. [71] and Theegarten et al. [72]. The first team presented the clinical, pathological 
and mineralogical findings from the examination of 7 patients previously exposed to dust 
containing high levels of airborne pollutants. The patients presented several symptoms, in-
cluding dyspnea, persistent cough and chest pain. Prompted by the patients’ unexplained ra-
diological findings, the clinicians decided to obtain lung bioptic material. The histopathologi-
cal images were complex as they revealed various types of fibrosis for 5 patients and bron-
chiolitis for 3 patients corroborating the patients' debilitating non-specific interstitial pneu-
monitis and restrictive lung disease. The mineralogical findings were equally diverse, with 
heavy loads of chrysotile asbestos, aluminum silicates and single-walled carbon nanotubes 
(SWCNT) in 3 out of 7 patients. The SWCNT appeared either alone or in pairs and were 
found to be of various lengths. Based on several in vivo studies, the authors highlighted that 
certain types of carbon nanotubes are pro-inflammatory, capable of inducing granulomas and 
causing lung injury that could lead to asbestos-like pathogenicity. However, they refrained 
from speculating on the exact causation of the symptoms, given that the examined patients 
were also exposed to toxic gases and fibrous and particulate materials of known toxic poten-
 tial were also deposited in their lungs at levels higher than normal. Theegarten et al. focused 
on a single patient who suffered from abdominal pain, diarrhea and presented weight loss. 
Biopsied peritoneal tissue contained carbon-based nanoparticles which had elicited a foreign-
body reaction. This type of material was in good accordance with the sort of particles emitted 
by laser printers, therefore the authors came to the conclusion that the detected objects must 
have entered through the respiratory tract and accumulated to the submesothelium of the peri-
toneum. The study showcases once again how even large nanoparticles (>60nm) might pass 
through the alveolar-capillary barrier and accumulate in tissues away from their point of en-
try. However, the simultaneous presence of Crohn alterations to colon biopsies undercuts the 
possible pernicious impact of the particles and their connection to systemic symptoms. 
Ex vivo exploration of the nanoparticulate load of clinical samples  
The common thread of the studies found in this section is that the presence of nano-
particles in the investigated samples was either an unexpected finding or an assumed possibil-
ity, at best. Naturally, the first step was to confirm their presence: retrieved samples were ob-
served by means of transmission or scanning electron microscopy and the detected objects 
were qualitatively analyzed by the acquisition of energy-dispersive X-ray spectra (EDS). 
Out of the 8 relevant papers, TEM images of the detected NP were available in the 
most recent of them [70-73]. Song et al. observed 20 to 80 nm sections of lung biopsies and 
chest fluids without submitting them to any prior treatment. This method allowed for the de-
tection of nano-sized particles, their morphological description, detailed localization and res-
olution of spatial interaction with subcellular organelles [73]. Moreover, follow-up observa-
tions in chest fluid over the course of several months hinted at the nanoparticles being elimi-
nated from the patients’ lower respiratory tract. At this point though, inherent limitations in 
TEM imaging, to which we alluded in the corresponding section of wear nanoparticles, ham-
pered the study: in brief, the size of observed nanoparticles had to be limited by the thickness 
 of the section (< 80 nm) and the calculated size distribution was ostensibly derived by a small 
and statistically insignificant fraction of the tissue or fluid in question.  
Alternatively, the older works from Gatti et al. mainly were constructed on the envi-
ronmental scanning electron microscope  (ESEM) imaging of colonic, renal and hepatic biop-
tic samples. ESEM is an electron microscope which performs well even in low vacuum con-
ditions and does not require prior metallization of the sample, thus reducing the number of 
preparation steps and the risk of introducing artefacts [64, 65, 69]. Complementary backscat-
ter electron (BSE) imaging was used to reveal the existence of nanoparticles covered by thin 
layers of cancerous tissue. Having said that, ESEM’s ability to resolve the size and morphol-
ogy of particles suffers in the nanometer scale, therefore it was only possible to trace clusters 
rather than individual nanoparticles and BSE images of tissue covered nanoparticles fail to 
clearly define their borders, rendering size measurements difficult for unknown nanoparticles 
[65]. 
Regarding the quantitation of detected nanoparticles, Wu et al. opted for an alkaline 
digestion of the bioptic tissue prior to TEM imaging and were thus able to estimate the con-
centration of SWCNT in grams per wet weight of tissue, albeit losing information on their 
exact site of residence (interstitial space, macrophages, epithelial cells, etc.) [71]. The only 
other quantitative approach was demonstrated by Song et al. : based on their assertion that 
silica nanoparticles in the lung tissue and pleural fluids should be held responsible for the 
grave condition of their patients, they performed an ICP-MS analysis on the sampled pleural 
effusion of patients [73]. The patient’s load of elemental Si was almost twice that of non-
exposed individuals, but it was not made clear what fraction of the measured quantity was 
specifically due to silicon-containing particulates and what fraction corresponded to the Si 
homeostasis of the patient. 
With the analytical tool of choice of being electron microscopy in tandem with EDS, it 
 had been possible to reveal essential information on the physicochemical nature of nanoparticles: 
size, shape and chemical composition. On the down-side, the size of the largest observable parti-
cle and the area of the investigated sample were limited by the thickness and total surface of the 
observed section, respectively. To overcome the above caveats and achieve statistical signifi-
cance in terms of size distribution, researchers usually observe multiple sites of the sample and 
count at least a few hundreds of particles. A commendable rethinking of electron microscopy 
practices can be found in the work of Elsaesser et al. which proposes the homogeneous embed-
ment of a known number of cells in a predetermined volume of a resin tube [74]. Across its 
length, random sections were imaged, thus resolving their subcellular localization and allowing 
the calculation of the nanoparticles’ number and size by image processing. On top of that, be-
cause the number of cells, thickness of sections and length of the cell-containing tube are known, 
statistical significance of the obtained data can be ascertained. 
In the context of exploratory studies, any objects of interest will always have to be de-
tected before attempting any other type of more in-depth analysis. In other words, electron 
microscopy will be a prerequisite to ensemble techniques, like DLS or ICP-MS. That is the 
reason why stereological, statistically exploitable imaging of samples like the one described 
above is of great importance: although ostensibly arduous, they present a big opportunity to 
acquire reliable qualitative and quantitative data as well as insight to the nanoparticles’ fate in 
the organism. Such possibilities bode well for investigating cell suspensions of liquid clinical 
samples, such as pleural effusions, alveolar lavages and whole blood. A thorough presenta-
tion of the latest advances in analytical techniques as and their advantages and drawbacks for 
the quantification of nanoparticles in biological environments has been compiled by Elsaesser 
et al. [75]. 
  
 Conclusions 
Engineered nanomaterials are increasingly integrated into industrial processes and 
find their way into products and services of the medical, construction and high-tech fields, 
forming a rapidly grossing market. It is thus safe to assume that occupational and environ-
mental exposure to nanoparticles is most likely to increase because of direct interactions with 
them or their by-products. In light of the asbestos hazards and the malicious effects of ultra-
fine particles, there is an unceasing scientific interest in the biopersistence of some of the 
most salient nanoparticles, as those are defined in the Organization for Economic Co-
operation and Development’s Series on the Safety of Nanomaterials No. 27. 
The clinically-oriented analysis of nanoparticles for the evaluation of their pathophys-
iological impact remains an unexplored field. As evidenced in this review, the quantitative 
and qualitative analysis of nanoparticles in human biological samples is a daunting scientific 
endeavor. Without protocols or instruments which are able to cope with the complexity of 
biological matrices, clinical studies rely on decades-old practices originally developed for 
material sciences and biochemistry. Their major shortcoming is the lack of quantitative as-
sessment of the nanoparticulate load in a given clinical sample; in consequence, qualitative 
data on the chemical composition, size and morphology of detected nanoparticles becomes 
potentially misrepresentative, too. Further complicating things, nanoparticles are often con-
current with larger particles or patients have been simultaneously exposed to other potentially 
harmful substances, thus obscuring the real impact of the nano-sized objects. 
In lack of official guidelines or unequivocal evidence which correlates nanoparticle 
exposure to human diseases, large epidemiological studies are too taxing in terms of person-
nel, time and financial resources. Instead, small, high-quality pilot studies based on well-
designed and reliable techniques for nanoparticle extraction and characterization from clini-
cal samples could help evolve the field of applied nanotoxicology. If such small-scale studies 
 present plausible links between bioaccumulated nanoparticles and some pathological condi-
tion, larger scale epidemiological studies should be the logical next step.  
Conclusively, research at the nano-bio interface will have to intensify. At the nanome-
trology front, there is already a lot of coordinated activity for the accurate and precise charac-
terization of various types of nano-objects, even under less than optimal conditions [76]. The 
European Union has funded a collaborative research project for the chemical and optical 
characterization of nanomaterials in biological samples (NanoChOp) and the U.S. National 
Science and Technology Council has recently identified the detection, quantification and 
characterization of nanomaterials in biological matrices as a standalone research necessity 
[77]. We believe that the purely methodological aspect of nanoparticle detection and extrac-
tion from biological samples can be improved at a local scale with the ad hoc utilization of 
clinical samples stored in hospitals. These samples are regularly retrieved and then stored for 
administrative purposes, effectively functioning as atypical specimen banks, and include 
body fluids like blood, mictional urine, broncho-alveolar lavages, follicular fluid, seminal 
fluid, various serous fluids as well as tissular bioptic material. Each of one them presents a 
unique analytical challenge, with its proper biochemical and physical characteristics, like pro-
tein, lipidic and cellular content, ionic strength, viscosity, type of tissue, etc. Familiarization 
with real-world samples might finally evoke key adaptations for enabling nano-scale tech-
niques and rendering them serviceable for nanotoxicology in a clinical context and thus solid-
ifying the  
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 Table 1 
 
 
 
Prosthesis Tissue Chemical treatment Physical treatment Analytical 
techniques 
Particle size in 
nanometers 
Particle 
composition 
References 
CoC n/a n/a Laser capture micro-
dissection 
EDS 
SEM 
TEM 
46 (SEM) 
5 (TEM) 
Al2O3 [35] 
MoP Femoral Alkaline digestion 
Delipidation 
Ethanol - induced protein 
precipitation 
Centrifugation, filtration EDS 
FEG-SEM 
30 UHMWPE [32] 
MoM n/a Enzymatic digestion 
Acetone 
SDS 
Tris-HCl 
Sonication, 
Centrifugation 
EDS 
Electron 
diffraction 
HRTEM 
40 CoCr 
Cr 
Ti 
[30] 
MoM Pseudo-capsular,  
interfacial and 
femoral membranes 
Alkaline digestion Sucrose gradient centrifuga-
tion 
Filtration 
BSE 
EDS 
FEG-SEM 
20 CoCrMo 
Ti 
[36] 
MoP Enzymatic digestion 
SDS 
Tris-HCl 
Centrifugation 
Sonication 
Filtration 
SEM <100 UHMWPE 
MoP Granulomatous Delipidation 
Acid digestion 
Freeze-drying 
Centrifugation, 
Sonication, 
Filtration 
EDS 
FEG-SEM 
FTIR 
18 UHMWPE [41] 
MoP Synovial capsule 
Bone - implant interface 
Typical EM preparation TEM <100 UHMWPE [34] 
MoM Pseudo-capsular,  
interfacial, femoral and  
acetabular membranes 
Tissue sections: 
Typical EM preparation 
TEM 
EDS 
6 Al 
CoCrMo 
Ti 
V 
[33] 
Extracted particles: 
Delipidation 
Enzymatic digestion 
SDS 
Tris-HCl 
Extracted particles: 
Lyophilization 
Centrifugation 
Sonication 
20 
MoM or 
MoP 
Lymph nodes Typical TEM or cryo-TEM preparation TEM 20 ZrO2 [24] 
 Table 2 
 
Pathology and / or  
clinical image 
Specimen Chemical  
treatment 
Physical treatment Analytical 
techniques 
Particle size in 
nanometers 
Particle 
composition 
References 
Diffused granuloma Liver biopsy Alcohol 
Xylol 
20µ sectioning 
 
 
EDS 
ESEM 
>50 Au [64] 
Ulcerative colitis 
Crohn’s disease 
Colon cancer 
Colon biopsies Alcohol 
Xylol 
20µ sectioning BSE 
EDS 
ESEM 
>30 Ag, Al, Ca, 
Fe, K, Na, S, 
Si, Ti 
[65] 
similar to: 
Usual and non-specific intersti-
tial pneumonitis 
Hypersensitivity pneumonia 
Lung biopsies Alkaline digestion of  
paraffin embedded 
lung tissue 
Centrifugation TEM 20 - 30 Carbon 
(SWCNT) 
[71] 
N/A Thrombi and tissue  
adherent to  
vena cava filters 
Formaldehyde Microtome section-
ing 
EDS 
ESEM 
Indistinguishable Al, C, K, O, 
S, Si 
[68] 
Shortness of breath 
Pleural and  
pericardial effusion 
Chest fluid 
Broncho - alveolar 
lavage fluid 
Lung tissue 
Typical TEM prepa-
ration 
Centrifugation TEM 30 N/A [70] 
Shortness of breath 
Pleural and  
pericardial effusion 
Lung tissue 
Chest fluid 
Xylene 
Typical TEM prepa-
ration 
Ultra-thin section-
ing (50 to 80 nm) 
AAS 
EDS 
ICP-MS 
TEM 
2-20 SiO2 [73] 
Deep vein thrombosis 
Abdominal cancer 
Thrombi and tissue  
adherent to  
vena cava filters 
N/A 5µ and 10µ  
sectioning 
EDS 
ESEM 
≥100 Various [69] 
Abdominal pain,  
weight loss, diarrhea 
Crohn’s alterations 
Submesothelial  
peritoneal tissue 
Formaldehyde 10µ sectioning EDS 
ESEM 
31 – 67 Carbon 
(particulate) 
[72] 
 Table captions 
 
Table 1. Summary of studies on the detection and analysis of nano-sized wear debris in 
periprosthetic samples.  
CoC, ceramic on ceramic; HRTEM, high-resolution TEM; MoM, metal on metal; MoP, metal 
on polyethylene; N/A, no specific information available; SDS, sodium dodecyl sulfate; SEM, 
scanning electron microscope. 
 
Table 2. An overview of all available clinical studies that investigated the presence of 
nanoparticles in various human specimens.  
AAS, atomic absorption spectroscopy; N/A, no specific information available; Various, C, O, 
Pb, Ca, Cu, Ag, Zn, Si, S, and P. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure captions 
 
Figure 1 
Locally: Nano- and micro-sized metallic wear debris undergo endocytosis or pinocytosis  and 
are eroded in the phagolysosomes of macrophage cells. Erosion of particles also happens in 
the extracellular space. Liberated metal ions are captured by protein molecules to form hapten 
adducts, which are in turn recognized as non-specific antigens by T- and B-lymphocytes, thus 
triggering a type IV hypersensitivity reaction. The immune system responds by the formation 
of pseudotumors which comprise of fibrin, macrophages and lymphocytes. The pro-
inflammatory cytokines IL-1β and TNF-α are produced. Local necrosis also liberates reactive 
oxygen species (ROS). Osteoclasts can be activated by the cytokines and ROS as well as by 
the osteoclasts differentiation factor (ODF) synthesized by macrophages that have engulfed 
particulate debris. Finally, activated osteoclasts initiate osteolysis. 
Systemically: Wear debris and macrophages that have phagocytozed it can migrate through 
the lymph system and accumulate at near-by or distal lymph nodes, carrying the risk of necro-
sis and inflammation. Metal ions can enter the blood circulation and pertain to a risk of sys-
temic toxicity. Finally, metal nanoparticles present a high risk of accumulation in the liver 
(inside clusters of macrophages or coming in contact with local blood vessels) and the spleen 
(inside granulomas developed in close proximity to lymphatic vessels). 
 
Figure 2 
A) TEM micrographs of nanometer sized shards of ceramic wear debris (indicated by arrows) 
from the femoral tissue of a ceramic-on-ceramic prosthesis. Adapted from Hatton et al. 2002 
and reprinted with permission from Elsevier [Biomaterials. Alumina-alumina artificial hip 
joints. Part I: a histological analysis and characterisation of wear debris by laser capture mi-
 crodissection of tissues retrieved at revision, 23(16): 3429-3440 (2002). Hatton A, Nevelos 
JE, Nevelos AA, Banks RE, Fisher J and Ingham E. Copyright 2002 Elsevier Limited]. 
B) FEG-SEM micrographs of 0.1µm polycarbonate membranes with UHMWPE wear parti-
cles. Aggregates of UHMWPE particles are small enough to enter the membrane pores. 
Adapted from Lapcikova et al. 2009 and reprinted with permission from Elsevier [Wear. Na-
nometer size wear debris generated from ultra high molecular weight polyethylene in vivo,  
266(1): 349-355 (2009). Lapcikova M, Slouf M, Dybal J, Zolotarevova E, Entlicher G, 
Pokorny D, Gallo J and Sosna A. Copyright 2009 Elsevier Limited]. 
 
Figure 3 
Major sources of qualitative and quantitative error introduced during the most common pre-
treatments of clinical samples for the extraction and isolation of nanoparticles. (A) TEM pic-
ture of a silica nanoparticle in deionized water and (B) TEM picture of a silica nanoparticle 
treated with sodium hypochlorite (scale bars at 20 nm). (C) TEM picture of zinc oxide (ZnO) 
nanoparticles in neutral pH (scale bar at 200 nm) and (D) TEM picture of ZnO nanoparticles 
in pH~11 (scale bar at 100 nm). (E) SEM picture of ZnO nanoparticles adhered to the walls of 
polypropylene tubes (scale bar at 10µm) and (F) SEM picture of ZnO nanoparticles aggregat-
ed at the bottom of a polypropylene tube after mild centrifugation at 14000×g for 10 minutes 
(scale bar at 1mm). (G) FEG-SEM picture of Au nanoparticles after filtering through a poly-
cellulose membrane of 0.22µm nominal pore size and (H) BSE micrograph of the area imaged 
in picture (G) showing Au nanoparticles trapped inside the filter (scale bars at 500 nm).  
 
Figure 4 
A) TEM micrographs of CNT in digested patient lung tissue appear as transparent tubes (indi-
cated by arrows) and are sporadically covered by metal particles (indicated by arrowhead). 
 Adapted from Wu et. al 2010 and reprinted with permission from NIEHS [Environmental 
Health Perspectives. Case Report: Lung Disease in World Trade Center Responders Exposed 
to Dust and Smoke: Carbon Nanotubes Found in the Lungs of World Trade Center Patients 
and Dust Samples, 118(4): 499-504 (2010). Wu M, Gordon RE, Herbert R, Padilla M, Moline 
J, Mendelson D, Litle D, Travis WD and Gil J. Copyright 2010 National Institute of Envi-
ronmental Health Sciences]. 
B) TEM micrographs of round nanoparticles of unknown composition in chest fluid (indicat-
ed by arrows) partially enclosed in a fibrous structure. Adapted from Song et al. 2009 and re-
printed with permission from ERS Journals [European Respiratory Journal. Exposure to na-
noparticles is related to pleural effusion, pulmonary fibrosis and granuloma, 34(3): 559-567 
(2009). Song Y, Li X and Du X. Copyright European Respiratory Society Journals Limited]. 
